/manager/Index ${session.getAttribute("locale")} 5 Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study /manager/Repository/uon:32621 -6) and followed by variants in GAPVD1 (GTPase activating protein and VPS9 domains 1; combined P-value 5.83 × 10-5) and near ZNF697 (combined P-value 8.15 × 10-5).]]> Tue 26 Jun 2018 14:58:14 AEST ]]> Familial recurrence risks for multiple sclerosis in Australia /manager/Repository/uon:13657 s) was similar across all sites. The familial recurrence risk of MS in Australia is lower than in previously reported studies. This is directly related to the lower population prevalence of MS. The overall genetic susceptibility in Australia as measured by the λs is similar to the northern hemisphere, suggesting that the difference in population risk is explained largely by environmental factors rather than by genetic admixture.]]> Sat 24 Mar 2018 08:25:18 AEDT ]]>